These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 9198047

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, Avram MM.
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [Abstract] [Full Text] [Related]

  • 4. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
    Baldus M, Salopek S, Möller M, Schliesser J, Klooker P, Reddig J, Gansert U, Brass H.
    Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Red cell zinc protoporphyrin and its ratio to serum ferritin (ZPP/logSF index) in the detection of iron deficiency in patients with end-stage renal failure on hemodialysis].
    Matuszkiewicz-Rowińska J, Ostrowski G, Niemczyk S, Przedlacki J, Wardyn K, Puka J, Włodarczyk D, Switalski M, Zakrzewska T, Ostrowski K.
    Pol Arch Med Wewn; 2003 Jul; 110(1):703-10. PubMed ID: 14682204
    [Abstract] [Full Text] [Related]

  • 7. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
    Bovy C, Gothot A, Delanaye P, Warling X, Krzesinski JM, Beguin Y.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1156-62. PubMed ID: 17237481
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Factors determining the percentage of hypochromic red blood cells in hemodialysis patients.
    Bovy C, Tsobo C, Crapanzano L, Rorive G, Beguin Y, Albert A, Paulus JM.
    Kidney Int; 1999 Sep; 56(3):1113-9. PubMed ID: 10469381
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Zinc protoporphyrin and percentage of hypochromic erythrocytes as markers of functional iron deficiency during therapy with erythropoietin in patients with advanced acquired immunodeficiency syndrome.
    Matzkies FK, Cullen P, Schaefer L, Hartmann M, Hohage H, Schaefer RM.
    South Med J; 1999 Dec; 92(12):1157-61. PubMed ID: 10624905
    [Abstract] [Full Text] [Related]

  • 16. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC, Hung SC, Tarng DC.
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Iron monitoring and supplementation: how do we achieve the best results?
    Schaefer RM, Schaefer L.
    Nephrol Dial Transplant; 1998 Jun; 13 Suppl 2():9-12. PubMed ID: 9566484
    [Abstract] [Full Text] [Related]

  • 19. Assessment of iron status by erythrocyte ferritin in uremic patients with or without recombinant human erythropoietin therapy.
    Caravaca F, Vagace JM, Aparicio A, Groiss J, Pizarro JL, Alonso N, Garcia MC, Arrobas M, Cubero J, Esparrago J.
    Am J Kidney Dis; 1992 Sep; 20(3):249-54. PubMed ID: 1519605
    [Abstract] [Full Text] [Related]

  • 20. Erythrocyte zinc protoporphyrin.
    Braun J.
    Kidney Int Suppl; 1999 Mar; 69():S57-60. PubMed ID: 10084287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.